Advanced glycation end products, oxidative stress and diabetic nephropathy.
about
Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulationDrug Targets for Oxidative Podocyte Injury in Diabetic NephropathyThe protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitroThe role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy.Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus.Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.Exogenous antioxidants--Double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses.Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signalingAdvanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.Inhibition of protein glycation by essential oils of branchlets and fruits of Juniperus communis subsp. hemisphaerica.Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans.Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs).Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension.Accumulation of advanced glycation end-products and activation of the SCAP/SREBP Lipogenetic pathway occur in diet-induced obese mouse skeletal muscleAqueous extract of some indigenous medicinal plants inhibits glycation at multiple stages and protects erythrocytes from oxidative damage-an in vitro study.Inhibitory activities of selected Kampo formulations on human aldose reductaseImmunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic miceSerum levels of receptors for advanced glycation end products in normal-weight and obese children born small and large for gestational age.Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathyCurcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stressSkin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes MellitusDiabetic nephropathy: What does the future hold?Glomerular cell death and inflammation with high-protein diet and diabetesRenal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats.The effect of an emollient with benfothiamine and Biolin prebiotic on the improvement of epidermal skin function.Overexpression of DJ-1 reduces oxidative stress and attenuates hypoxia/reoxygenation injury in NRK-52E cells exposed to high glucose.Ginseng extracts restore high-glucose induced vascular dysfunctions by altering triglyceride metabolism and downregulation of atherosclerosis-related genes.Involvement of Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Advanced Glycation End Products-Induced Glomerular Mesangial Cell Injury.Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.Exercise and Beta-Glucan Consumption (Saccharomyces cerevisiae) Improve the Metabolic Profile and Reduce the Atherogenic Index in Type 2 Diabetic Rats (HFD/STZ).A review of recent advances and current hypotheses on the pathogenesis of acute laminitis.The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.Have we reached the limits for the treatment of diabetic nephropathy?The selected traditional chinese medicinal formulas for treating diabetic nephropathy: perspective of modern science.
P2860
Q26766645-7138A4A4-7C9E-4D37-B0F9-E16DAFF30708Q26769787-D59B6858-7113-447A-9541-5E9EF19D9FF8Q28487614-A36E0DBE-B6CB-4146-9407-2687D3A79427Q33557060-F57D4354-6B7F-499D-AC13-CB6B11D40323Q33622283-C5C8BED6-EE0F-4C94-BFA3-2C57D364FBF3Q33928779-F74B09EB-DAFC-4EB8-961D-15907BDCA8CAQ34185794-3D2342BF-4595-4D26-A0A1-474780211016Q34185801-C7583B6A-021C-4E7E-A4AB-9639E6D064B7Q34409300-FAE576EC-4EE8-48E8-AF44-E0C2EC5919E4Q34776889-4C39050B-4BC4-41A5-9333-B7B51F81BFAAQ34838338-C7B0C22B-8016-4885-BF5B-034207B203ACQ35022648-A68008D9-8226-4489-9200-1C61B8FEB593Q35029632-8DF11722-1FA1-47FD-AE6C-118D4675C806Q35125191-E09AF87A-96E5-4740-AEEA-12805672E560Q35157945-485B26BB-E50C-4533-8728-3AE52366CACFQ35157953-443CCFEF-2AFE-4E03-8896-CD4FEF7BC46FQ35157962-15572177-9FA1-4639-9DD2-26F3579AFC5FQ35159141-2889DB80-BB29-4D02-A9BB-D79E96F3FCFFQ35220870-6075E389-FAB6-4894-B29F-569FC34DE9D4Q35397913-F7B4BD21-7435-4631-9F88-CFCE744547D5Q35766118-A8D64B1B-4463-4455-AB28-9ABFD8D28CFCQ35976551-942C8FDA-EF61-4AF1-9622-AE5C5EBC5F20Q36188834-21E2EE4A-E734-4AC6-BDC8-25A5C1FE9D2EQ36249547-E697C8F1-2972-4276-9ACA-5EAD2E28E206Q36252773-05C07126-CBF6-48B0-89F3-B719A345F577Q36264876-FBEB6746-F7EA-4F45-8A94-D1D8C9B82CAFQ36386660-A8B3061F-6722-43AB-9BF0-E53D6C2DF76AQ36441616-9237A99D-A138-424F-8563-71551E303468Q37000229-35441F32-82D0-4DB5-97AA-DC18187A5426Q37019804-9964D923-1F88-455A-B2DA-40FB29428CE5Q37143992-D9317E30-F6A6-4447-9451-3432F9523966Q37187517-5FA08634-1ABE-44F6-AF3A-95E8F9D10A6EQ37249857-CE58EDFD-EACD-4F53-97FC-D3AEAE83B3BFQ37281682-9BF69A37-4613-42C8-9055-D41553A447AFQ37396756-B77AB037-57E0-4449-B2E0-7EDED356B222Q37535439-408BE8B0-9BB8-4DB5-B890-E58B8D9A81B3Q38056179-B0A0570A-C66D-4A33-A744-BA15FDC73175Q38144642-E6283319-9F48-46EE-9469-CC23BED2EF9FQ38189884-6FACA4C5-5C87-4127-9054-D84D9301F398Q38203282-81A2DDF0-0745-4004-82F2-745CFE829170
P2860
Advanced glycation end products, oxidative stress and diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@en
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@nl
type
label
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@en
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@nl
prefLabel
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@en
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@nl
P2860
P356
P1476
Advanced glycation end products, oxidative stress and diabetic nephropathy.
@en
P2093
Sho-Ichi Yamagishi
Takanori Matsui
P2860
P304
P356
10.4161/OXIM.3.2.11148
P577
2010-03-01T00:00:00Z